Investigational Drug Information for Soticlestat
✉ Email this page to a colleague
What is the drug development status for Soticlestat?
Soticlestat is an investigational drug.
There have been 12 clinical trials for Soticlestat.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 29th 2021.
The most common disease conditions in clinical trials are Syndrome, Lennox Gastaut Syndrome, and Epilepsies, Myoclonic. The leading clinical trial sponsors are Takeda, Millennium Pharmaceuticals, Inc., and Ovid Therapeutics Inc.
There are ten US patents protecting this investigational drug and forty-five international patents.
Summary for Soticlestat
| US Patents | 10 |
| International Patents | 45 |
| US Patent Applications | 30 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 2 (2021-09-29) |
| Vendors | 23 |
Recent Clinical Trials for Soticlestat
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience | Takeda | Phase 1 |
| A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc Interval | Takeda | Phase 1 |
| A Study of Soticlestat Tablets in Healthy Adults | Takeda | Phase 1 |
Clinical Trial Summary for Soticlestat
Top disease conditions for Soticlestat
Top clinical trial sponsors for Soticlestat
US Patents for Soticlestat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Soticlestat | ⤷ Try a Trial | 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka, JP) | ⤷ Try a Trial |
| Soticlestat | ⤷ Try a Trial | 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka, JP) | ⤷ Try a Trial |
| Soticlestat | ⤷ Try a Trial | 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka, JP) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Soticlestat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Soticlestat | Argentina | AR088226 | 2031-10-07 | ⤷ Try a Trial |
| Soticlestat | Australia | AU2012321815 | 2031-10-07 | ⤷ Try a Trial |
| Soticlestat | Brazil | BR112014007257 | 2031-10-07 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
